A Phase 2 Study of Intratumoral Administration of L19IL2/L19TNF in Locally Advanced Cutaneous Squamous Cell Carcinoma Patients Progressing on or Intolerant to Systemic Treatment
Latest Information Update: 20 Nov 2025
At a glance
- Drugs Bifikafusp alfa/onfekafusp alfa (Primary)
- Indications Cutaneous B-cell lymphoma; Squamous cell cancer
- Focus Therapeutic Use
- Sponsors Philogen
Most Recent Events
- 20 Nov 2025 New trial record